key: cord-0797598-8ghlqp11
authors: Shah, Vishank Arun; Nalleballe, Krishna; Onteddu, Sanjeeva Reddy
title: Critically Ill Neurologic Patients During The COVID-19 Pandemic: A Short Communication
date: 2021-01-19
journal: Brain Behav Immun Health
DOI: 10.1016/j.bbih.2021.100207
sha: ae90654d2a8c33f41f9d71d2b0a34ad5fbd5c054
doc_id: 797598
cord_uid: 8ghlqp11

PURPOSE: We aimed to evaluate utilization of inpatient hospital and critical care services in critically ill neurologic patients during the COVID-19 pandemic. We hypothesized based on prior observations in ischemic stroke patients, that there would be significant decline in critically ill neurologic patients presenting to hospitals during the pandemic which may impact outcomes. METHODS: We used TriNetX, a large research network, collecting real-time electronic medical records data. We extracted data on utilization of critical care and hospital inpatient services among cohorts of patients with common neurocritical conditions between January-June 2020 compared to similar time-frame in previous years. We also compared the prevalence and clinical outcomes comprising need for intubation and 30-day mortality among these cohorts. RESULTS: We found a 28.1% reduction in intensive care unit (ICU) admissions with critical neurologic illnesses in 2020 when compared to 2019 (8568 vs. 11917 patients, p<0.0001) and a 34.4% reduction compared to 2018 (8568 vs. 13064 patients, p<0.0001). However, there was no statistically significant difference in mortality (2020: 12.2 vs. 2019: 12.4% ; p=0.7; vs. 2018: 12.6%; p=0.62) or intubation rates across the years among patients using critical care services. There was 1% increase in mortality among non-ICU patients with similar diagnoses in 2020 compared to previous years (2020: 3.9% vs. 2019: 2.9% vs. 2018: 3.1%; p<0.0001, p=0.0001), but no difference in intubation rates. CONCLUSION: There was a significant reduction in hospital and ICU admissions among patients with acute neurologic emergencies in 2020, after onset of COVID-19 pandemic, compared to previous years. While we did not find a significant difference in mortality among patients admitted to the ICU, there was slightly higher mortality among non-ICU patients with same diagnoses in 2020 compared to previous years. Prospective evaluation and further investigation into the reasons for these trends is needed.

Reports from Italy 1 have demonstrated that the COVID-19 pandemic has imposed an overwhelming demand on healthcare systems leading to resource rationing 2 . Critically ill neurologic patients are often perceived to have poor outcomes leading to premature limitation in care even prior to the pandemic 3 .

Therefore, during a COVID-19 surge, these patients may receive limited care leading to worse outcomes.

Additionally, neurologic disease and COVID-19 infection may co-exist, either as a manifestation of COVID-19 infection 4 , a consequence of severe systemic illness such as hypoxia, or in the form of simultaneous COVID-19 infection in patients with primary neurologic illness. Each of these scenarios may impact outcomes in patients with neurologic disease during the COVID-19 pandemic. For example, COVID-19 patients with acute encephalopathy have been shown to have a significantly higher mortality 5 . Finally, under-utilization of healthcare during the pandemic among ischemic stroke patients has been reported in several studies 6 , 7 , and this may apply to other critically ill neurologic patients as well, influencing their outcomes. Neuro-critical care (NCC) units across the country have been converted to COVID-19 units and neurointensivists have had to care for COVID-19 patients, diverting care from critically ill neurologic patients. Despite above, utilization of healthcare and outcomes in critically ill neurologic patients during the COVID-19 pandemic have not been studied. We hypothesized that there has been a significant reduction in admissions among critically ill neurologic patients during the COVID-19 pandemic and sought to compare mortality in these patients between 2020 and previous years.

Appropriate approval was obtained from the Institutional Review Board (IRB). We performed our study using de-identified patient information extracted from the TriNetX database, a global collaborative clinical research platform collecting electronic medical record (EMR) data longitudinally in real-time from a network of health care organizations (HCO) in the U.S. and some U.S. territories. Since TriNetX extracts EMR data in real-time, there is no lag between patient hospitalization and entry into the database.

J o u r n a l P r e -p r o o f However, given TriNetX is de-identified, it does not provide individual patient data, permit data downloads and does not provide hospital level information, such as hospital size. At University of Arkansas for Medical Sciences the data from TriNetX is managed by Arkansas Clinical Data Repository (AR-CDR) and maintained by the Department of Biomedical Informatics.

We performed a retrospective cross-sectional cohort analysis in the form of independent queries by two physicians, using browser and real-time features of TriNetX. Patients hospitalized with the 5 most common neurocritical diagnoses (Table 1 ) and needing critical care services were identified between January 20 (the date the first COVID-19 case was reported in the U.S.) and June 15, 2020 using ICD-10 codes ( Table 1) . We restricted our time-frame to January to June 2020 to evaluate trends during the first wave of the pandemic. A comparison cohort was identified in an identical manner between January 20 to June 15, 2019. Baseline demographics, co-morbidities and clinical outcomes, including intubation rates and 30-day mortality were compared in both the cohorts. Outcomes were compared after propensity-score matching for co-morbidities and baseline characteristics. To ensure that reduction in number of patients was not restricted only to the ICU, but across all hospitalizations, we additionally extracted data on patients with identical ICD-10 codes that used hospital inpatient services without using critical care services. Similarly to ensure that there was a true decrease in 2020 and not simply an expected temporal variation, we also compared the 2020 cohort to a cohort comprising hospital and critical care admissions in 2018. Statistical analysis was performed through TriNetX analytics function. Co-morbidities were compared using independent samples t-test and outcomes were compared using z-test. P-values were obtained at a significance level of < 0.05.

There were 8,568 critically ill neurologic patients in 2020 and 11,917 in 2019 utilizing critical care services (Table 1) . While the TriNetX database may contain data from outside U.S.A., majority of the HCOs in our cohorts were from the U.S. (99.7% from U.S., 0.3% outside U.S.A.) (Supplement). In both the cohorts, mean age was 58.5-58.8 years, 44-45% were female, 66-68% were Caucasian, 22-24% Black, 2% Asian and 7-9% Hispanic ethnicity. Demographics and comorbidities in the 2020 versus 2019 cohorts were not significantly different ( Table 1 ).

The prevalence of simultaneous COVID-19 infection among critically ill neurologic patients was 1.4%, with the highest proportion in patients with AIS (1.7%), followed by TBI (0.9%) and ICH (0.9%). The number of patients with SAH, SE, NME and simultaneous COVID-19 infection was < 10 per group, a threshold below which TriNetX cannot extract a specific number.

Among critically neurologic patients utilizing ICU services, there was a 28.1% reduction in 2020 when compared to 2019 (2020: 8,568 vs. 2019: 11,917; p<0.0001). There was a 27.1% reduction in admissions with subarachnoid hemorrhage (SAH), 25.4% with intracerebral hemorrhage (ICH), 29.6% with acute ischemic stroke (AIS), 32.1% with status epilepticus (SE), 24.4% with traumatic brain injury (TBI) and 48.3% with neuromuscular emergencies (NME) (Guillian-Barré syndrome and myasthenia gravis exacerbation) (p<0.0001 for all) ( 

With respect to outcomes, there was no significant difference in 30-day mortality (12.2 vs. 12.4%, p=0.7).

or intubation rates (7.8% vs. 8.4%, p=0.14) among critically ill neurologic patients utilizing ICU services in 2020 versus 2019. There was no statistically significant difference in mortality across individual diagnoses as well (Table 2) . Similarly, there was no difference in overall mortality when compared to 2018 (12.2% vs. 12.6%, p=0.62). However, among hospitalized patients not receiving ICU care, there was a 1% increase in mortality in 2020 compared to 2019 and a 0.8% increase compared to 2018 and while numerically small, this difference was statistically significant (2020: 3.9% vs. 2019: 2.9% vs. 2018:

3.1%; p<0.0001).

Reduction in hospitalizations among AIS patients during the COVID-19 pandemic has been reported previously 6 , 8 . We suspected a similar pattern with other critically ill neurologic and neurosurgical patients, however, this has not been described previously. Our study showed an overall reduction in utilization of critical care services by 28-35% among patients with acute neurologic/neurosurgical emergencies in the U.S. hospitals between 2020 versus previous years (2019 and 2018). Similarly, there was a 25-27% reduction in non-ICU hospitalizations among patient with neurologic/neurosurgical emergencies. The reason for this reduction remains unclear, but could be multifactorial. There may have been apprehension among patients due to fear of contracting COVID-19 infection in the hospitals, even though there are no reports of in-hospital provider-to-patient transmission so far. This hypothesis needs to be confirmed and corroborated with first responder data, which was not available in TriNetX.

Additionally, there may be limited ICU bed availability with diversion of patients to non-ICU floors, an expected outcome of a pandemic, although we also found a reduction in non-ICU hospitalizations in patients with these diagnoses.

While several studies have described neurologic manifestations in COVID-19 infection 4 , the prevalence of simultaneous COVID-19 in neurologic/neurosurgical patients has not been previously described. We found that simultaneous COVID-19 infection in critically ill neurologic/neurosurgical patients was low (1.4%). This low prevalence could be due to lower number of admissions and due to under-reporting, given testing may not have been performed in these patients as they do not meet traditional COVID-19 testing criteria. Additionally, lower prevalence may be due to significant regional heterogeneity across the U.S., given our cohort of patients was not balanced across all U.S. regions (Supplement).

Despite a reduction in hospitalizations and utilization of critical care services, we did not find a significant increase in mortality after onset of COVID-19 pandemic among critically ill neurologic patients that needed ICU care. This may indicate that ICU care has likely not been impacted in most centers. However, among patients hospitalized with these diagnoses but not receiving critical care there was mild increase in mortality during the pandemic, compared to previous years. The reasons for this trend need further exploration but may due to reduced ICU bed availability leading to more severe patients, that would ordinarily have been cared for in the ICU, being managed in non-critical care settings and by providers that lack specific expertise. Critically ill neurologic patients have been shown to have better outcomes when managed by specially trained neurocritical care personnel in dedicated neurocritical care units 9 and during the pandemic this care may not have been available or patients may have been admitted to general medical ICUs due to simultaneous COVID-19 infections. These hypotheses need further study as this data was not available in TriNetX. Additionally, patients with underlying chronic neurologic disorders such as myasthenia gravis, epilepsy, may have been more compliant with medications and outpatient follow up due to fear of needing inpatient services during the pandemic and this may have had led to reduced hospitalizations. Similarly, prevalence trauma may have declined due to lockdowns in the early phase of the first wave of the pandemic. These hypotheses also need further evaluation as we were not able to delineate this information through TriNetX. In addition, the true mortality could be significantly higher as we could not capture pre-hospital deaths, which may have J o u r n a l P r e -p r o o f occurred in patients prior to presentation. This needs to be corroborated with first-responder data. Finally, as the pandemic continues to evolve, there may be a delayed collateral impact on critically ill neurologic patients. Guidelines to ensure adequate care for NCC patients during the pandemic 9 should be adopted widely.

There are several limitations in our study, including its retrospective nature, reporting bias associated with using ICD-10 codes and inability to balance the severity of illness in both the cohorts. Additionally our cohorts do not account for regional heterogeneity in the COVID-19 pandemic and heterogeneity in care based on hospital size and level of care. As described above, we could not confirm several of our hypotheses for reduction in hospitalizations and critical care utilization among this patient population, due to limitations in the database. Finally, with the pandemic still ongoing, the true collateral impact on outcomes may not be evident till the pandemic has concluded. Lastly, we were unable delineate functional outcomes which are important outcome measures in neurologic patients.

There has been a significant reduction in hospitalization and utilization of critical care services among critically ill neurologic/neurosurgical patients during onset the COVID-19 pandemic in the U.S., without significant increase in mortality. Prospective studies are needed to confirm our findings, determine the true extent of collateral impact of COVID-19 on care of critically ill neurologic/neurosurgical patients and to determine factors contributing to reduction in healthcare utilization by this patient population. J o u r n a l P r e -p r o o f 

Hospital surge capacity in a tertiary emergency referral centre during the COVID-19 outbreak in italy

Fair allocation of scarce medical resources in the time of covid

Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies

Spectrum of neuropsychiatric manifestations in COVID-19

Acute encephalopathy is associated with worse outcomes in COVID-19 patients

Underutilization of health care for strokes during the COVID-19 outbreak

Collateral effect of covid-19 on stroke evaluation in the united states

Impact of the COVID-19 epidemic on stroke care and potential solutions

There was 28.1% reduction in admissions among critically ill neurologic an neurosurgical patients during the COVID-19 pandemic, suggesting under-utilization of healthcare services

There was no difference in mortality of intubation rates during the COVID-19 pandemic when compared to 2019 among critically ill neurological/neurosurgical patients 3. 1.4% of critically ill neurologic/neurosurgical patients had simultaneous COVID-19 infection with the highest prevalence among acute ischemic stroke patients

J o u r n a l P r e -p r o o f

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:J o u r n a l P r e -p r o o f